Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

726 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Current status and future perspectives of cooperative study groups for lung cancer in Japan.
Kawano Y, Okamoto I, Fukuda H, Ohe Y, Nakamura S, Nakagawa K, Hotta K, Kiura K, Takiguchi Y, Saka H, Okamoto H, Takayama K, Semba H, Kobayashi K, Kenmotsu H, Tsuboi M, Yamamoto N, Nukiwa T, Nakanishi Y. Kawano Y, et al. Among authors: ohe y. Respir Investig. 2014 Nov;52(6):339-47. doi: 10.1016/j.resinv.2014.06.004. Epub 2014 Jul 24. Respir Investig. 2014. PMID: 25453377 Review.
Chemoradiotherapy for lung cancer.
Ohe Y. Ohe Y. Expert Opin Pharmacother. 2005 Dec;6(16):2793-804. doi: 10.1517/14656566.6.16.2793. Expert Opin Pharmacother. 2005. PMID: 16318430 Review.
Once-weekly epoetin-beta improves hemoglobin levels in cancer patients with chemotherapy-induced anemia: A randomized, double-blind, dose-finding study.
Morishima Y, Ogura M, Yoneda S, Sakai H, Tobinai K, Nishiwaki Y, Minami H, Hotta T, Ezaki K, Ohe Y, Yokoyama A, Tsuboi M, Mori K, Watanabe K, Ohashi Y, Hirashima K, Saijo N; Japan Erythropoietin Study Group. Morishima Y, et al. Among authors: ohe y. Jpn J Clin Oncol. 2006 Oct;36(10):655-61. doi: 10.1093/jjco/hyl097. Epub 2006 Sep 20. Jpn J Clin Oncol. 2006. PMID: 16987908 Clinical Trial.
Epidermal growth factor receptor mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib-treated patients with lung adenocarcinoma.
Toyooka S, Takano T, Kosaka T, Hotta K, Matsuo K, Ichihara S, Fujiwara Y, Soh J, Otani H, Kiura K, Aoe K, Yatabe Y, Ohe Y, Mitsudomi T, Date H. Toyooka S, et al. Among authors: ohe y. Cancer Sci. 2008 Feb;99(2):303-8. doi: 10.1111/j.1349-7006.2007.00688.x. Cancer Sci. 2008. PMID: 18271929 Free PMC article.
726 results